Concepedia

Andrea Pirzkall

AP

Statistics

Publications

21

Citations

1.9K

H-Index

19

Active since

2010

Affiliations

University of Colorado Denver(Current)

Peter MacCallum Cancer Centre

Massachusetts General Hospital

Gene Therapy Laboratory

University of Colorado Cancer Center

Andrea Pirzkall is an author at University of Colorado Denver specializing in cancer therapeutics, medicine, and oncology.

Top concepts

Publications per year

2010–2019

21

Publications

21

Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non–Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib

Elizabeth A. Punnoose, Siminder Atwal, Weiqun Liu et al. · Clinical Cancer Research · 2012 · 417 citations

Molecular Biomarker Analyses Using Circulating Tumor Cells

Elizabeth A. Punnoose, Siminder Atwal, Jill M. Spoerke et al. · PLoS ONE · 2010 · 294 citations · Full text

Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors

Kyung Hae Jung, Patricia LoRusso, Howard A. Burris et al. · Clinical Cancer Research · 2019 · 281 citations · Full text

Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors

Asha Nayak-Kapoor, Zhonglin Hao, Ramses Sadek et al. · Journal for ImmunoTherapy of Cancer · 2018 · 150 citations · Full text

Changes in 18F-Fluorodeoxyglucose and 18F-Fluorodeoxythymidine Positron Emission Tomography Imaging in Patients with Non–Small Cell Lung Cancer Treated with Erlotinib

Linda Mileshkin, Rodney J. Hicks, Brett Hughes et al. · Clinical Cancer Research · 2011 · 121 citations · Full text

1–5 of 21